These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3104262)

  • 21. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
    Daskivich TJ; Oh WK
    Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase III studies in prostatic cancer with leuprolide acetate.
    Seely JH
    J Androl; 1987; 8(1):S23-6. PubMed ID: 3104263
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of the intranasal administration of LHRH superanalogue on endogenous LHRH in humans.
    Matsubara M; Koyanagawa Y; Nakagawa K
    Horm Metab Res; 1989 Feb; 21(2):104-5. PubMed ID: 2498194
    [No Abstract]   [Full Text] [Related]  

  • 24. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
    Garnick MB; Glode LM; Smith JA; Max DT
    Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
    [No Abstract]   [Full Text] [Related]  

  • 25. Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.
    Labrie F; Cusan L; Séguin C; Bélanger A; Pelletier G; Reeves J; Kelly PA; Lemay A; Raynaud JP
    Int J Fertil; 1980; 25(3):157-70. PubMed ID: 6108924
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment.
    Wenderoth UK; Jacobi GH
    Prog Clin Biol Res; 1985; 185A():297-305. PubMed ID: 3162176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion.
    Zheng JY; Fulu MY
    Int J Pharm; 2006 Jan; 307(2):209-15. PubMed ID: 16300912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical manipulation of leuprorelin acetate to improve clinical performance.
    Toguchi H
    J Int Med Res; 1990; 18 Suppl 1():35-41. PubMed ID: 2138986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.
    Okada H; Inoue Y; Heya T; Ueno H; Ogawa Y; Toguchi H
    Pharm Res; 1991 Jun; 8(6):787-91. PubMed ID: 1905810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy over time of LHRH analogs in the treatment of PCa--a prospective analysis using serum testosterone to determine dosing intervals.
    Greil S; Robinson EA; Singal B; Kleer E
    Urology; 2009 Mar; 73(3):631-4. PubMed ID: 19110301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
    Cox MC; Scripture CD; Figg WD
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):605-11. PubMed ID: 16111462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Galenic innovation: Enantone monthly depot preparations].
    Hübner R
    Urologe A; 1991 May; 30(3 Suppl):7-8. PubMed ID: 1746074
    [No Abstract]   [Full Text] [Related]  

  • 34. [Risk of current methods in contraception].
    Zufferey MM
    Rev Med Suisse Romande; 1985 Feb; 105(2):147-50. PubMed ID: 3885360
    [No Abstract]   [Full Text] [Related]  

  • 35. First report on the efficacy of l-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs.
    Plourde F; Motulsky A; Couffin-Hoarau AC; Hoarau D; Ong H; Leroux JC
    J Control Release; 2005 Nov; 108(2-3):433-41. PubMed ID: 16182402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LHRH analogs--a new treatment in hormone-dependent tumors].
    Wilking N; Rutqvist LE; Theve T
    Lakartidningen; 1988 Feb; 85(8):620-3. PubMed ID: 3280927
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone.
    Purswell BJ; Wilcke JR
    J Reprod Fertil Suppl; 1993; 47():335-41. PubMed ID: 8229946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [LH-RH treatment of patients with prostatic cancer by subcutaneous injection, non-biodegradable and biodegradable slow delivery system and intranasal spray application].
    Imai K; Saruki K; Totsuka Y; Shimizu N; Yamanaka H; Kitaura K; Tomaru Y; Nakamura T; Koya A; Yazima H
    Nihon Hinyokika Gakkai Zasshi; 1987 Mar; 78(3):411-9. PubMed ID: 3116307
    [No Abstract]   [Full Text] [Related]  

  • 39. Leuprolide depot before myomectomy.
    Friedman AJ
    Fertil Steril; 1990 Jun; 53(6):1109-10. PubMed ID: 2112497
    [No Abstract]   [Full Text] [Related]  

  • 40. Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration.
    Sennello LT; Finley RA; Chu SY; Jagst C; Max D; Rollins DE; Tolman KG
    J Pharm Sci; 1986 Feb; 75(2):158-60. PubMed ID: 3083092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.